Search all medical codes

Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg

HCPCS code

Medical Policies and Guidelines for Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg

Related policies from health plans

Phesgo (pertuzumab/trastuzumab/hyaluronidase-zzxf)

Similar Codes


ICD10CM codes

Z51.12 - Encounter for antineoplastic immunotherapy
Z29.1 - Encounter for prophylactic immunotherapy
Z30.013 - Encounter for initial prescription of injectable contraceptive
Z30.42 - Encounter for surveillance of injectable contraceptive
Z51.1 - Encounter for antineoplastic chemotherapy and immunotherapy
Z92.850 - Personal history of Chimeric Antigen Receptor T-cell therapy
Z51.11 - Encounter for antineoplastic chemotherapy
Z29.13 - Encounter for prophylactic Rho(D) immune globulin
T80.90XA - Unspecified complication following infusion and therapeutic injection, initial encounter
L10.5 - Drug-induced pemphigus

HCPCS codes

J9316 - Injection, pertuzumab, trastuzumab, and hyaluronidase-zzxf, per 10 mg
J9356 - Injection, trastuzumab, 10 mg and Hyaluronidase-oysk
J9306 - Injection, pertuzumab, 1 mg
Q5116 - Injection, trastuzumab-qyyp, biosimilar, (trazimera), 10 mg
C9467 - Injection, rituximab and hyaluronidase, 10 mg
J9022 - Injection, atezolizumab, 10 mg
J9311 - Injection, rituximab 10 mg and hyaluronidase
J3241 - Injection, teprotumumab-trbw, 10 mg
J9303 - Injection, panitumumab, 10 mg
C9061 - Injection, teprotumumab-trbw, 10 mg

CPT4 codes

90284 - Immune globulin (SCIg), human, for use in subcutaneous infusions, 100 mg, each
96402 - Chemotherapy administration, subcutaneous or intramuscular; hormonal anti-neoplastic
11900 - Injection, intralesional; up to and including 7 lesions
96401 - Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic
11954 - Subcutaneous injection of filling material (eg, collagen); over 10.0 cc
80280 - Vedolizumab
67515 - Injection of medication or other substance into Tenon's capsule
90750 - Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use
80230 - Infliximab
96379 - Unlisted therapeutic, prophylactic, or diagnostic intravenous or intra-arterial injection or infusio